Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence, with news that reflects its activities across Academia & Government, Intellectual Property and Life Sciences & Healthcare. Company announcements frequently highlight new AI-powered tools, analytical reports and customer adoptions that illustrate how Clarivate combines enriched data, analytics and workflow software.
Recent news includes the launch of the Web of Science Research Assistant, a generative AI-powered tool that helps researchers conduct natural-language searches, perform literature reviews and explore visualizations based on more than 120 years of publication and citation data. Clarivate also reports on studies such as the Pulse of the Library report, which surveys thousands of librarians worldwide about AI adoption, open science and budget pressures, and on the annual Highly Cited Researchers list, which recognizes researchers whose work has had broad influence based on Web of Science data.
In Intellectual Property, Clarivate issues updates on solutions like IPfolio and Derwent Patent Monitor, including customer selections by organizations such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation. These stories emphasize how IP management platforms and AI-enabled patent review tools support more efficient IP operations and collaboration between IP and R&D teams.
Life sciences and healthcare news often centers on Clarivate analyses such as the Drugs to Watch report and Companies to Watch reports, which identify emerging therapies and innovative companies using integrated, AI-enhanced datasets. Visitors to this news page can follow Clarivate’s product launches, research reports, customer case studies and investor-related announcements to understand how the company is applying data and AI across its core markets.
Clarivate Plc (NYSE: CLVT) announced the pricing of a $1.0 billion private offering of 3.875% senior secured notes due 2028 and $1.0 billion of 4.875% senior notes due 2029. The offering's proceeds will finance the acquisition of ProQuest, set to finalize by November 8, 2021, and cover associated fees. The notes will not be guaranteed before the acquisition but will be secured by escrow accounts. The offering is intended for qualified institutional buyers, with interests payable semi-annually starting December 30, 2021.
Clarivate Plc (NYSE: CLVT) announced a private offering of up to $1.0 billion in senior secured notes due 2028 and $1.0 billion in senior unsecured notes due 2029. The offering, subject to market conditions, aims to finance the purchase price for the pending acquisition of ProQuest, announced on May 17, 2021. The proceeds will be held in escrow until acquisition conditions are met, with redemption provisions if conditions are not satisfied by November 8, 2021. The notes will be secured prior to acquisition completion and will be guaranteed by subsidiaries post-acquisition.
Clarivate Plc (NYSE: CLVT) has priced concurrent offerings of 38,461,538 ordinary shares at $26.00 each and 12,500,000 5.25% Series A Mandatory Convertible preferred shares at $100 each. The offerings are expected to close on June 14, 2021. The company anticipates net proceeds of approximately $723.8 million from the ordinary shares and $1.208 billion from the preferred shares. The funds will primarily finance the pending acquisition of ProQuest, announced on May 17, 2021. The convertible preferred shares will convert into ordinary shares on June 1, 2024, if not redeemed earlier.
Clarivate Plc (NYSE: CLVT) announced on June 8, 2021, the proposed offerings of $750 million in ordinary shares and $1.25 billion in Series A Mandatory Convertible preferred shares. These offerings, which total $2 billion, aim to finance its pending acquisition of ProQuest. The completion of either offering is independent and subject to market conditions. If the acquisition does not proceed, proceeds will be used for general corporate purposes. The convertible preferred shares will convert into ordinary shares on June 1, 2024.
Clarivate Plc (NYSE:CLVT) has launched the COVID-19 Vaccine Availability and Medtech Impact Report, forecasting vaccination rates across countries in 2021. The report indicates that vaccine acceptance varies by region, with rates of 94% in Malaysia and 71% in the U.S. It highlights the importance of vaccination in recovering healthcare markets post-pandemic, particularly for Ambulatory Surgery Centers (ASCs) which showed higher utilization rates. The predictive analysis leverages real-world data to aid healthcare stakeholders in planning and decision-making.
Clarivate Plc (NYSE: CLVT) has announced a commercial partnership with Explore IP to integrate Derwent™ patent data into its platform. This collaboration aims to enhance the searchability of intellectual property data, enabling businesses and innovators to identify and understand patents held by Canadian public sector institutions. The partnership will facilitate licensing opportunities and foster innovation by providing access to authoritative patent information. This integration will support Canadian entrepreneurs and significantly improve the marketability of public sector technologies.
On May 26, 2021, Clarivate Plc (NYSE: CLVT) announced that its Executive Chairman and CEO, Jerre Stead, along with CFO Richard Hanks, will present at three upcoming virtual investor conferences in June 2021. The conferences include: William Blair's 41st Annual Growth Stock Conference on June 2 at 10:00 am CT, Baird's 2021 Global Consumer, Technology & Services Conference on June 8 at 12:15 pm ET, and Stifel's 2021 Virtual Cross Sector Insight Conference on June 10 at 8:00 am ET. Live webcasts will be available for each event.
Summary not available.
On May 18, 2021, Clarivate Plc (NYSE:CLVT) announced a strategic partnership with Alt Legal, Inc. to integrate CompuMark™ international trademark data into Alt Legal's platform. This collaboration aims to enhance Alt Legal's offerings by providing access to 186 trademark databases globally. The integration will allow users to receive updates on trademark filings, streamline workflows, and minimize human error. Alt Legal is responding to client demand for broader international capabilities, positioning itself as a leading docketing solution for global trademark management.
Clarivate (NYSE: CLVT) has agreed to acquire ProQuest for $5.3 billion, enhancing its position as a leading provider of research intelligence solutions. The deal includes $4 billion in cash and $1.3 billion in equity, with expected closing in Q3 2021. ProQuest serves over 25,000 institutions globally, and this acquisition will expand Clarivate’s data offerings significantly. Financially, the transaction is projected to be accretive to earnings, with anticipated cost synergies exceeding $100 million within 15-18 months, paired with substantial cash tax savings.